Fresenius Financial Statements From 2010 to 2024

FSNUY Stock  USD 8.71  0.05  0.58%   
Fresenius financial statements provide useful quarterly and yearly information to potential Fresenius SE Co investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Fresenius financial statements helps investors assess Fresenius' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Fresenius' valuation are summarized below:
Fresenius SE Co does not presently have any fundamental signals for analysis.
Check Fresenius financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fresenius' main balance sheet or income statement drivers, such as , as well as many indicators such as . Fresenius financial statements analysis is a perfect complement when working with Fresenius Valuation or Volatility modules.
  
This module can also supplement various Fresenius Technical models . Check out the analysis of Fresenius Correlation against competitors.

Fresenius SE Co Company Profit Margin Analysis

Fresenius' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Profit Margin

 = 

Net Income

Revenue

X

100

More About Profit Margin | All Equity Analysis

Current Fresenius Profit Margin

    
  0.04 %  
Most of Fresenius' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fresenius SE Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition

Based on the latest financial disclosure, Fresenius SE Co has a Profit Margin of 0.0402%. This is 100.36% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The profit margin for all United States stocks is 103.17% lower than that of the firm.

Fresenius SE Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Fresenius's current stock value. Our valuation model uses many indicators to compare Fresenius value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Fresenius competition to find correlations between indicators driving Fresenius's intrinsic value. More Info.
Fresenius SE Co is rated # 2 in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers reporting about  0.37  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Fresenius SE Co is roughly  2.72 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Fresenius by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Fresenius' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Fresenius Financial Statements

Fresenius investors use historical fundamental indicators, such as Fresenius' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Fresenius. Please read more on our technical analysis and fundamental analysis pages.
KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Hhe, Germany. Fresenius operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 318647 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Fresenius Pink Sheet Analysis

When running Fresenius' price analysis, check to measure Fresenius' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius is operating at the current time. Most of Fresenius' value examination focuses on studying past and present price action to predict the probability of Fresenius' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius' price. Additionally, you may evaluate how the addition of Fresenius to your portfolios can decrease your overall portfolio volatility.